Navigation Links
Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks

nd other pain related conditions. POZEN is also exploring the development of product candidates in other pain-related therapeutic areas. POZEN has a development and a commercialization alliance with GlaxoSmithKline. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN".

For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

    POZEN Inc. sponsored and GlaxoSmithKline supported these studies.


    Contacts:

    GSK US Media                  Robin Gaitens, 919-483-2839

    GSK US Analyst/Investor       Frank Murdolo, 215-751-7002

                                  Tom Curry, 215-751-5419


    POZEN Inc. Investor           Bill Hodges, Chief Financial Officer,

                                  919-913-1030

                                  Fran Barsky, Director, Investor Relations,

                                  919-913-1044

    POZEN Inc. Media              Andrea Johnston, Pure Communications,

                                  910-681-1088

CONTACT: Robin Gaitens, +1-919-483-2839, or Analyst/Investor, FrankMurdolo, +1-215-751-7002, or Tom Curry, +1-215-751-5419, all ofGlaxoSmithKline; or Bill Hodges, Chief Financial Officer, +1-919-913-1030,or Fran Barsky, Director, Investor Relations, +1-919-913-1044 both of POZENInc., or Media, Andrea Johnston of Pure Communications, +1-910-681-1088,for POZEN Inc.

Ticker Symbol: (:POZN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
3. Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA
4. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
5. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
6. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
7. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
8. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
9. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
10. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
11. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
Post Your Comments:
(Date:8/20/2014)... Glenmark Pharmaceuticals S.A. (GPSA), ... India (GPL), announces the discovery and initiation of ... candidate, GBR 1302, a HER2xCD3 bispecific antibody. GBR ... Biologics Research Centre located in La Chaux-de-Fonds, ... on Glenmark,s innovative BEAT antibody technology platform which ...
(Date:8/19/2014)... BIRMINGHAM, Ala. , Aug. 19, 2014  The Alabama ... re-affirmed that patients can sue drug makers who mislead doctors ... cause harmful side‑effects.  The case is Weeks v. Wyeth, and ... drug makers in that same case last year. Heninger Garrison ... represent the patient in the case, Danny Weeks ...
(Date:8/19/2014)... -- Minimally Invasive Devices Inc. (MID), a ... that Mitsubishi Corporation has formally agreed to exclusively distribute ... Japan . MID anticipates that FloShield will ... in the second half of 2015. ... Storz GMBH & Co. (endoscopic instruments and devices) in ...
Breaking Medicine Technology:Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2
... achieve undetectable viral load in Phase,IIa trial within ... care, SAN FRANCISCO, Nov. 1 New ... protease inhibitor (PI) being,developed by Tibotec BVBA for ... Tibotec will present findings from three TMC435 studies,including ...
... Higher Sustained Virological Response Rates Recognized as Marker ... 1 A new,independently-conducted study being presented at ... the Study of Liver Diseases (AASLD) shows that,PEGASYS(R) ... response (SVR) rates for hepatitis C patients as,compared ...
Cached Medicine Technology:Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 2Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 4Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 2New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 3New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 4New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 6New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 7
(Date:8/20/2014)... August 20, 2014 Doctors at the University ... wipe out mesothelioma in laboratory mice by injecting them with ... posted details of the study on its website. Click ... with Hong Kong University’s AIDS Institute of Microbiology created a ... or PD-1. By altering DNA, the vaccine is designed to ...
(Date:8/20/2014)... Today, Zane Benefits, the #1 Online ... for 2015. , According to Zane Benefits, with open ... employees are encouraged to start thinking about their healthcare ... open enrollment period will run from November 15, 2014 ... can purchase a new individual health insurance policy, or ...
(Date:8/20/2014)... 20, 2014 The report “Automotive ... - A Global Analysis: by Geography - Trends ... classifies and defines automotive airbag and seatbelt market ... highlights potential growth opportunities in the coming years ... market drivers, restrains, growth indicators, challenges, legislation trends, ...
(Date:8/20/2014)... August 20, 2014 In a recent ... a University College London (UCL) study showed that dental ... method of brushing teeth was the most effective. Analysis ... different tooth-brushing techniques were frequently recommended, but none were ... for Cosmetic Dentistry, experienced cosmetic dentist Dr. ...
(Date:8/20/2014)... Hope For The Warriors® is excited to announce ... in Washington, DC on Thursday, October 2, 2014 at ... the courage of our wounded service members, their families, ... Got Heart, Give Hope® Celebration will benefit Hope For ... sense of self, restoring the family unit, and restoring ...
Breaking Medicine News(10 mins):Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2
... May 19 Towards the Electronic,Patient Record ... interface terminology,announced today its next-generation interface terminology ... terminologies access to all of,IMO,s terminology knowledge ... algorithms optimized for millisecond response times in ...
... Sciences (OTC,Bulletin Board: DSCI), a provider of advanced ... Burn Dressing, its flagship wound care,product, was profiled ... Reporter Lisa Thomas-Laury examines the use of ... Leonard Abrams Center for Advanced Wound,Healing of the ...
... Health, Inc., one of,the nation,s largest public/private health ... provider of software agent,technologies for health information exchange, ... clinicians at the point of care., Shared ... the clinical,interface capabilities of what is already one ...
... Should Be ,Wake-Up Call, for Doctors and Women, WASHINGTON, ... coronary artery disease are significantly less likely than,men to be ... WomenHeart - the national coalition for women with heart,disease -- ... sure,that women are getting the care that they need., ...
... May 19 Edifecs, the leader in ... EDS has,selected the Edifecs Healthcare Accelerator Suite ... health care transactions in both,real-time and batch ... of the,EDS MetaVance(R) Administration and Finance System., ...
... of Liverpool has performed a groundbreaking operation on a chimp ... dogs. , The three year-old chimp called Janet was rescued ... in a chimpanzee reserve supported by the Cameroon Wildlife Aid ... because a bone in her forearm - the ulna - ...
Cached Medicine News:Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 3Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 4Health News:Derma Sciences' MEDIHONEY(TM) Profiled By ABC News' Philadelphia Affiliate 2Health News:Shared Health(R) and Novo Innovations Partner for Improved Information-Sharing of Clinical Health Records 2Health News:Shared Health(R) and Novo Innovations Partner for Improved Information-Sharing of Clinical Health Records 3Health News:Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks 2Health News:EDS Selects Edifecs Healthcare Accelerator Suite for Claims Processing Solution 2Health News:Surgeon operates to rescue chimp with rare deformity 2
... and model 1488 active-fixation leads are among ... the unsurpassed handling advantages, performance, and reliability ... active-fixation leads. Implantable with a 7 F ... Tendril SDX lead is designed to lower ...
... CheckPoint is an automated, wireless, computerized ... alert system for refrigerator, freezer, incubator ... recorders, data loggers and manual temperature ... an existing PC and comes complete ...
... This requiring no water for ... hand hygiene to physically clean ... is either not an option ... allows you to return to ...
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
Medicine Products: